AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as ...

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ongoing $3.5 billion investment in American innovation.

On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials assessed the efficacy and safety of ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

Tariffs are "certainly not material long term," Soriot said, adding that AstraZeneca will rely on the existing global network to shift manufacturing as needed. That includes 11 manufacturing sites in ...

Biotech AstraZeneca goes in vivo, penning $1B deal for Belgian off-the-shelf cell therapy biotech By James Waldron Mar 17, 2025 7:40am AstraZeneca mergers and acquisitions Cell & Gene Therapy CAR-T ...

AstraZeneca has refuted allegations its staff “refuse to cooperate and respect” the U.K. marketing code. The drugmaker successfully defended itself against claims senior staff ignored requests ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said ...

AstraZeneca had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. AstraZeneca aims to grow revenue by about 75% to ...

AstraZeneca’s Covid shot uses a cold virus common to chimpanzees as a viral vector to carry the spike protein from the coronavirus into cells. “AstraZeneca is very good, but the mRNA products ...

Last year, AstraZeneca leased the 84,000-square-foot space on 9950 Medical Center Drive, which was one of the largest leases in Montgomery County in 2023, according to commercial real estate firm ...

AstraZeneca AZN 0.79% has agreed to buy Gracell Biotechnologies for a transaction value of $1.2 billion, as part of the former’s efforts to grow its cell therapies business. The upfront cash ...